Key result
High bleeding risk status is linked to ~4-fold higher major bleeding in ACS post-PCI.
Why the study?
Although patients with high bleeding risk undergoing PCI have poor outcomes, detailed characteristics and outcomes in ACS patients with HBR have not been fully clarified.
Does high bleeding risk (HBR) status affect clinical outcomes and coronary lesion characteristics in patients with acute coronary syndrome undergoing OCT-guided PCI?
Cohort (n=961)
Does high bleeding risk (HBR) status affect clinical outcomes and coronary lesion characteristics in patients with acute coronary syndrome undergoing OCT-guided PCI?
Answers are grounded in this paper and cite their sources.
ACS patients with high bleeding risk undergoing OCT-guided PCI have more advanced atherosclerosis (calcified nodules and plaques) and significantly higher rates of major bleeding and cardiac death at 2 years.
INTRODUCTION: Although it is well-known that patients with high bleeding risk (HBR) who undergo percutaneous coronary intervention (PCI) have poor clinical outcomes, the details have not been fully clarified for acute coronary syndrome (ACS) population. The aim of this study was to describe patient and lesion characteristics in patients with ACS and HBR as defined by the Academic Research Consortium (ARC). METHODS: Patients with ACS (n = 961) who underwent optical coherence tomography (OCT)-guided PCI were investigated. They were divided into HBR and non-HBR groups according to the ARC HBR criteria. Clinical background, lesion characteristics on angiography and OCT, and clinical outcomes during the 2-year follow-up period were compared between the groups. RESULTS: The HBR group comprised 307 patients (32%). The frequency of multi-vessel coronary disease was higher in the HBR group than the non-HBR group (34% vs. 26%, p = 0.015). OCT findings demonstrated a higher frequency of calcified nodules as the underlying pathology for ACS in the HBR group (12% vs. 3%, p < 0.001), with a correspondingly higher frequency of calcified plaques (55% vs. 39%, p < 0.001). Kaplan-Meier estimates of the incidence of major bleeding (11.0% vs. 2.4%, p < 0.001) and cardiac death (8.5% vs. 2.4%, p < 0.001) were more prevalent for the HBR group than the non-HBR group during the follow-up period. CONCLUSION: ACS patients with HBR factors had more advanced atherosclerosis which contributed to a higher prevalence of cardiac death as well as major bleeding complications.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2025) conducted a cohort in Acute Coronary Syndrome (n=961). High bleeding risk (HBR) vs. Non-HBR was evaluated on Major bleeding (p=<0.001). High bleeding risk in ACS patients undergoing OCT-guided PCI was associated with a higher 2-year incidence of major bleeding and cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: